AmeriCares and Baxter work together to save lives in Haiti with donation to help Stem Cholera outbreak
AmeriCares and Baxter International Inc. have teamed to deliver additional lifesaving intravenous (IV) solutions to Haiti as part of their ongoing effort to stem the cholera outbreak. AmeriCares has been working around the clock to distribute IV solutions, oral rehydration salts, antibiotics, hand sanitizers and other critical aid since the outbreak was reported in October. As a leading manufacturer of products used in the delivery of fluids and drugs to patients, Baxter's donations have been an integral part of the response. AmeriCares airlifted an additional 50,000 pounds of aid over the weekend which will be used to re-supply depleted stocks at cholera treatment centers and hospitals in Port-au-Prince.
Baxter has donated IV rehydration solutions and IV sets to administer the solutions that will help to bring lifesaving aid to at least 25,000 patients suffering in Haiti. Baxter has teamed with AmeriCares for nearly 25 years to share its innovative products and treatments with people in need throughout the world and has an ongoing commitment to work with AmeriCares to meet the needs of Haiti. Recently, Baxter has pre-positioned medicines and solutions in the AmeriCares warehouse, ready to be mobilized in the event of an emergency such as this cholera outbreak.
'It is estimated that more than 300,000 people will be hospitalized with cholera in the next six to eight months. This donation from Baxter is essential to getting ahead of this deadly, but treatable, disease,' President and CEO of AmeriCares, Curt Welling, said. 'AmeriCares has worked closely with Baxter since 1987, responding to health care needs around the world. They have been generous with their products and understand the value of providing lifesaving aid to the world's most vulnerable populations.'
By working together, AmeriCares and Baxter will not only help treat patients currently suffering from cholera, but will pre-position critical aid so it is ready to be delivered directly into the hands of health care professionals treating people newly diagnosed. In one month alone, 15,000 Haitians have been hospitalized for cholera. For those with acute cholera, it requires eight liters of IV solution to rehydrate and save their life. Without proper rehydration, patients can die within 10-12 hours if not treated right away.
About AmeriCares
AmeriCares is a nonprofit global health and disaster relief organization which delivers medicines, medical supplies and aid to people in need around the world and across the United States. Since it was established in 1982, AmeriCares has distributed more than $10 billion in humanitarian aid to 147 countries. For more information, visit www.AmeriCares.org.
Related news
-
Daxor Corporation to Commence Trading on the Nasdaq Capital Market
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that it will commence trading on The Nasdaq Capital Market effective at the opening of trading on February 2, 2022, transferring the listing of its common stock from the New York Stock Exchange – American. Daxor’s common stock will continue trading under the ticker symbol “DXR” after the transfer. The Company’s common stock will continue to trade on the NYSE American until the...
-
The Indoor Microbiome and Its Impact on Indoor Environmental Quality
Last year, the U.S. Environmental Protection Agency (EPA) announced the release of a new webpage to provide information about the indoor microbiome. All of the living microorganisms inside of an indoor environment, and their by-products, are collectively known as the indoor microbiome. The indoor microbiome that surrounds each of us is diverse and dynamic, made up of bacteria, viruses, fungi and other single-celled organisms. These microorganisms may be growing or inactive, and may be present in different life...
-
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh will present a corporate overview at the H.C. Wainwright BioConnect 2022 Virtual Conference, which is taking place on January 10 – 13, 2022. Mr. Feldshuh will provide company updates and key highlights, including a new patent award and progress with BVA-100® next generation development. The presentation will be available on-demand beginning at 7:00 a.m. ET...
-
Daxor Announces Key Milestones Achieved for Multicenter BVA-100 Study in Hospitalized Patients With COVID-19
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces patient enrollment is complete and data analysis is underway in preparation for publication of the multi-center observational prospective study utilizing Daxor’s BVA-100 (Blood Volume Analyzer, “BVA”) technology in hospitalized COVID-19 patients. NYU Langone Health, Wake Forest School of Medicine and OHSU have been enrolling subjects since the onset of the pandemic. Dr. Jan Bakker, MD,...
-
Daxor Awarded New Patent for Blood Volume Guidance Technology to Improve Treatment & Outcomes
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announced that the United States Patent and Trademark Office has issued the company a new patent (U.S. Patent No. 11,204,356 B2) that protects a proprietary clinical guidance system for volume management utilizing unique volume metrics combined with treatment pathways. “We are very excited to receive this patent, which covers key innovations in the use of blood volume analysis to optimally guide fluid...
Customer comments
No comments were found for AmeriCares and Baxter work together to save lives in Haiti with donation to help Stem Cholera outbreak. Be the first to comment!